Andrzej Myc

This inventor holds 12 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignee: University of Michigan. Active years: 2003-2021.

USPTO Granted Patents = 12 (Patent Applications = 4)

% Patents Active = 83.3

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 3.6

ph-index = 6

Forward Citations = 314(Granted Patents)

Company Filing History:

12 out of 3,511

University of Michigan

patents

Years Active: 2003-2021

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11116825 - Cancer vaccine compositions and methods of using the same (2021-09-14),

2. 10138279 - [object Object] (2018-11-27),

3. 9974844 - Cancer vaccine compositions and methods of using the same (2018-05-22),

4. 9839685 - Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen (2017-12-12),

5. 8771731 - Antimicrobial nanoemulsion compositions and methods (2014-07-08),

6. 8236335 - Antimicrobial nanoemulsion compositions and methods (2012-08-07),

7. 8232320 - Antimicrobial nanoemulsion compositions and methods (2012-07-31),

8. 7767216 - Antimicrobial compositions and methods of use (2010-08-03),

9. 7655252 - Antimicrobial nanoemulsion compositions and methods (2010-02-02),

10. 6635676 - Non-toxic antimicrobial compositions and methods of use (2003-10-21),

11. 6559189 - Non-toxic antimicrobial compositions and methods of use (2003-05-06),

12. 6506803 - Methods of preventing and treating microbial infections (2003-01-14),

Title: Andrzej Myc: Innovator in Cancer Vaccine Research

Introduction

Andrzej Myc is a prominent inventor based in Ann Arbor, MI (US), known for his significant contributions to the field of cancer vaccine research. With a total of 12 patents to his name, Myc has been at the forefront of developing innovative methods and compositions aimed at stimulating immune responses.

Latest Patents

Among his latest patents, Myc has developed compositions and methods for cancer vaccine applications. One notable invention provides methods and compositions for the stimulation of immune responses, particularly through nanoemulsion compositions. These compositions are designed to induce both innate and adaptive immune responses, which are crucial for generating host immunity against environmental pathogens. His work finds applications in clinical settings, including therapeutic and preventative medicine, as well as in research applications. Another patent focuses on methods of inducing an immune response to bacteria, providing valuable tools for both therapeutic and research purposes.

Career Highlights

Andrzej Myc is affiliated with the University of Michigan, where he continues to advance his research in immunology and vaccine development. His innovative work has positioned him as a key figure in the scientific community, contributing to the understanding and treatment of cancer through vaccine technology.

Collaborations

Myc collaborates with esteemed colleagues, including James R Baker, Jr and Tarek Hamouda, enhancing the impact of his research through shared expertise and knowledge.

Conclusion

Andrzej Myc's contributions to cancer vaccine research exemplify the importance of innovation in the medical field. His patents and ongoing research efforts are paving the way for new therapeutic strategies in combating cancer.